Results 101 to 110 of about 25,354 (147)

The change in the pharmacological significance of dihydralazine (Germany) and hydralazine (USA). [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Mech C, Seifert R.
europepmc   +1 more source

Atherectomy Followed by Drug-Coated Balloon Angioplasty Versus Surgery for Symptomatic Deep Femoral Artery Arteriosclerotic Disease. [PDF]

J Endovasc Ther
Torsello GB, Gouveia E Melo R, Zeller T, Böhme T, Korosoglou G, Coscas R, Stavroulakis K, Kapetanios D, Torsello GF, Nasr B.   +9 more
europepmc   +1 more source

Circulating mitochondrial biomarkers in acute coronary syndrome. [PDF]

Front Med (Lausanne)
Iboleon-Jimenez A, Sánchez-Quintero MJ, Carmona-Segovia ADM, Sojo B, Fernández-Ramos AM, García-Rodríguez L, Molina-Ramos AI, García-Pinilla JM, Jimenez-Navarro M, Ortega-Gomez A.   +9 more
europepmc   +1 more source

Global comparison of the economic costs of coronary heart disease: a systematic review and meta-analysis. [PDF]

BMJ Open
Shakya S, Shrestha A, Robinson S, Randall S, Mnatzaganian G, Brown H, Boyd J, Xu D, Lee CMY, Brumby S, Peeters A, Lucas J, Gauci S, Huxley R, O'Neil A, Gao L.   +15 more
europepmc   +1 more source

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial. [PDF]

Mult Scler
Selmaj KW, Steinman L, Comi G, Bar-Or A, Arnold DL, Hartung HP, Montalbán X, Havrdová EK, Sheffield JK, Krakovich A, Cheng CY, Riolo JV, Pachai C, Thorpe A, DeBoer E, Kappos L, Cohen JA, Cree BA.   +17 more
europepmc   +1 more source

Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort study. [PDF]

EBioMedicine
Olbrich H, Kridin K, Hernández G, Zirpel H, Sadik CD, Terheyden P, Thaçi D, Ludwig RJ, Boch K.   +8 more
europepmc   +1 more source

Radiofrequency ablation via catheter and transpapillary access in patients with cholangiocarcinoma (ACTICCA-2 trial) - a multicenter, randomized, controlled, open-label investigator-initiated trial. [PDF]

BMC Cancer
Schmidt C, Zapf A, Ozga AK, Canbay A, Denzer U, De Toni EN, Lohse AW, Schulze K, Rösch T, Stein A, Wege H, von Felden J.   +11 more
europepmc   +1 more source

Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk. [PDF]

Genome Med
Georgakis MK, Malik R, Bounkari OE, Hasbani NR, Li J, Huffman JE, Shakt G, Tack RWP, Kimball TN, Asare Y, Morrison AC, Tsao NL, Judy R, Mitchell BD, Xu H, Montasser ME, Do R, Kenny EE, Loos RJF, Terry JG, Carr JJ, Bis JC, Psaty BM, Longstreth WT, Young KA, Lutz SM, Cho MH, Broome J, Khan AT, Wang FF, Heard-Costa N, Seshadri S, Vasan RS, Palmer ND, Freedman BI, Bowden DW, Yanek LR, Kral BG, Becker LC, Peyser PA, Bielak LF, Ammous F, Carson AP, Hall ME, Raffield LM, Rich SS, Post WS, Tracy RP, Taylor KD, Guo X, Mahaney MC, Curran JE, Blangero J, Clarke SL, Haessler JW, Hu Y, Assimes TL, Kooperberg C, Bernhagen J, Anderson CD, Damrauer SM, Zand R, Rotter JI, de Vries PS, Dichgans M.   +64 more
europepmc   +1 more source

Distinct inflammatory pathways shape atherosclerosis in different vascular beds. [PDF]

Eur Heart J
Soehnlein O, Lutgens E, Döring Y.
europepmc   +1 more source

Characterisation of Symptom and Polysomnographic Profiles Associated with Cardiovascular Risk in a Sleep Clinic Population with Obstructive Sleep Apnoea. [PDF]

Nat Sci Sleep
Kemp E, Sutherland K, Bin YS, Chan ASL, Dissanayake H, Yee BJ, Kairaitis K, Wheatley JR, de Chazal P, Piper AJ, Cistulli PA, Sydney Sleep Biobank Investigators.   +11 more
europepmc   +1 more source